Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

90.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
90.7K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

960
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
960
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Depression: Overview01:18

Depression: Overview

1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concerns About Self-Safety or Own Emotional Regulation in the Home are Both Associated With Suicidal Ideation: A Risk Factor Warranting Research and Policy Attention.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2026
Same author

Putting Lived Experience at the Centre: A Critical Review of Multidisciplinary, Person-Centred Mental Health Care.

Journal of multidisciplinary healthcare·2026
Same author

Risk of all-cause and cause-specific mortality, and suicide attempt in people with anxiety and stress-related disorders: a systematic review, meta-analysis and meta-regression analysis of 165 studies.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
Same author

Body dysmorphic symptoms in autism and attention-deficit hyperactivity disorder: A comorbidity study.

The Australian and New Zealand journal of psychiatry·2026
Same author

A Multi-Symptom Circuit Architecture of Obsessive-Compulsive Disorder.

medRxiv : the preprint server for health sciences·2025
Same author

Magnetoencephalography during a saccadic eye movement task in anorexia nervosa.

Psychiatry research·2025

Related Experiment Video

Updated: Apr 21, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.8K

Difficult-to-treat-depression: what do general practitioners think?

Kay M Jones1, David J Castle2, Eleanor M Curran2

  • 1Monash University, Melbourne, VIC, Australia. kay.jones@monash.edu.

The Medical Journal of Australia
|November 6, 2014
PubMed
Summary
This summary is machine-generated.

General practitioners (GPs) often struggle with diagnosing and managing difficult-to-treat depression (DTTD). They prioritize practical patient care over complex classifications, highlighting the need for accessible resources and support for these patients.

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

65
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

31.8K
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

65
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.0K

Area of Science:

  • General Practice
  • Mental Health
  • Qualitative Research

Background:

  • Difficult-to-treat depression (DTTD) presents unique challenges in primary care settings.
  • General Practitioners (GPs) are often the first point of contact for patients with depression.

Purpose of the Study:

  • To explore general practitioners' perspectives on managing patients with difficult-to-treat depression (DTTD).
  • To identify challenges and facilitators in the diagnosis and management of DTTD from a GP viewpoint.

Main Methods:

  • Qualitative study utilizing focus groups and semi-structured telephone interviews.
  • 10 General Practitioners (GPs) from urban and rural Victoria participated.
  • Explored GPs' understanding and experiences with DTTD diagnosis and management.

Main Results:

  • GPs demonstrated limited recognition and questioned the relevance of diagnostic terms for DTTD.
  • Management guidelines were perceived as not always helpful, with difficult access to psychiatric support.
  • Non-pharmacological treatments, patient-provider relationships, and addressing environmental/cultural factors were deemed important for adherence.

Conclusions:

  • GPs prioritize practical patient management over diagnostic classifications for DTTD.
  • Gaps exist in GPs' knowledge of literature and available resources for DTTD.
  • Enhanced support and resources are needed to improve the management of difficult-to-treat depression in primary care.